What Is Emergency Use Authorization (EUA)?
Emergency Use Authorization (EUA) is a regulatory mechanism that allows the temporary use of unapproved medical products, or unapproved uses of approved products, during declared public health emergencies. It enables rapid access to potentially life-saving interventions when no adequate, approved, and available alternatives exist.
Emergency authorization frameworks are implemented by authorities such as the U.S. Food and Drug Administration, European Medicines Agency, Medicines and Healthcare products Regulatory Agency, Health Canada, Therapeutic Goods Administration, and Central Drugs Standard Control Organization. These frameworks support rapid regulatory response during pandemics, outbreaks, and other public health crises.
Purpose of Emergency Use Authorization
| Objective |
Description |
| Rapid Access |
Early availability of vaccines, medicines, and diagnostics |
| Public Health Protection |
Address urgent medical needs during emergencies |
| Risk–Benefit Balance |
Ongoing safety oversight while enabling access |
| Regulatory Flexibility |
Temporary authorization based on available evidence |
Conditions for Granting EUA
Although criteria vary by region, common requirements include:
| Requirement |
Explanation |
| Public Health Emergency |
Official declaration by relevant authority |
| Potential Effectiveness |
Reasonable belief that product may be effective |
| Benefit–Risk Assessment |
Benefits outweigh known and potential risks |
| Lack of Alternatives |
No adequate, approved, and available alternative |
Regional Frameworks
United States
| Aspect |
Description |
| Legal Basis |
Federal Food, Drug, and Cosmetic Act |
| Emergency Declaration |
Secretary of Health and Human Services |
| Data Requirements |
Available clinical, nonclinical, manufacturing, and safety data |
| Clinical Development |
Phase III completion not always required |
| Nature of Authorization |
Temporary with specific conditions of use |
| Safety Obligations |
Mandatory adverse event reporting and fact sheets |
| Revocation |
Authorization may be withdrawn if risks outweigh benefits |
European Union
| Mechanism |
Description |
| Conditional Marketing Authorization |
Based on less comprehensive data; valid for one year, renewable |
| Temporary National Authorizations |
Issued by member states during emergencies |
United Kingdom
| Authority |
Mechanism |
| Medicines and Healthcare products Regulatory Agency |
Temporary authorization under national legislation during emergencies |
Canada
| Authority |
Mechanism |
| Health Canada |
Interim orders permitting emergency authorization based on scientific evidence |
Australia
| Authority |
Mechanism |
| Therapeutic Goods Administration |
Provisional approval pathways or emergency access mechanisms |
India
| Authority |
Mechanism |
| Central Drugs Standard Control Organization |
Restricted emergency approval for vaccines and drugs with ongoing monitoring |
Post-Authorization Requirements
| Requirement |
Description |
| Continued Clinical Trials |
Ongoing studies to confirm safety and effectiveness |
| Additional Data Submission |
Sponsors must provide updated evidence |
| Pharmacovigilance |
Enhanced safety monitoring and periodic safety updates |
| Risk Management Plans |
Implementation of structured safety measures |
| Withdrawal Possibility |
Authorization may be revoked if benefit is not confirmed |
Key Differences: EUA vs Full Approval
| Parameter |
Emergency Use Authorization |
Full Approval |
| Evidence Standard |
Reasonable belief of effectiveness |
Substantial evidence of safety and efficacy |
| Data Completeness |
Interim or limited data may be accepted |
Complete data from well-controlled trials |
| Duration |
Temporary; linked to emergency period |
Permanent marketing authorization |
| Regulatory Status |
Conditional with specific obligations |
Comprehensive approval following full review |
Real-World Applications
During major public health emergencies such as the COVID-19 pandemic, vaccines, antiviral medicines, and diagnostic tests were made available under emergency authorization frameworks before receiving full approval. This facilitated faster public health response while maintaining regulatory oversight and ongoing safety monitoring.
Emergency Use Authorization plays a critical role in global health preparedness by enabling timely access to essential medical products while preserving regulatory standards and post-authorization safety surveillance.
Sign in with Google
